SURVEY OF FATALITIES FROM SKIN TESTING AND IMMUNOTHERAPY 1985-1989

被引:295
作者
REID, MJ
LOCKEY, RF
TURKELTAUB, PC
PLATTSMILLS, TAE
机构
[1] ALLERGY & IMMUNOL MED ASSOCIATES,SAN FRANCISCO,CA
[2] JAMES A HALEY VET HOSP,TAMPA,FL
[3] US FDA,CTR BIOL EVALUAT & RES,ALLERGY & IMMUNOCHEM LAB,BETHESDA,MD 20014
[4] UNIV VIRGINIA,CHARLOTTESVILLE,VA 22903
[5] UNIV S FLORIDA,TAMPA,FL 33620
关键词
SKIN TESTING; IMMUNOTHERAPY; ASTHMA; ANAPHYLAXIS;
D O I
10.1016/0091-6749(93)90030-J
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The Committee on Allergen Standardization of the American Academy of Allergy and Immunology (AAAI) began a study of fatalities associated with skin testing and immunotherapy in an effort to identify risk factors and to ascertain whether any additional precautions are required to prevent and treat serious reactions. Methods: Questionnaire data was obtained from members of the AAAI and the American College of Allergy and Immunology, regarding 17 fatalities associated with immunotherapy for the years 1985 to 1989. In this period, no fatalities were reported with skin testing. The mean age of patients who died was 36.0 years (range: 10 to 77 years), and 69% were female. Of the patients who died, 76% had asthma, and most were reported to have had factors associated with severity (i.e., lability, required steroids, and/or prior hospitalizations). The only patient who had rhinitis alone had cardiovascular disease and was receiving a beta-blocker High sensitivity by skin test or RAST was reported by 71%, and 36% reported prior systemic reactions. Sixty-five percent of the patients were undergoing build-up therapy. Fatalities involved use of allergen doses between 1:1 million to 1:10 wt/vol. Other factors associated with fatalities were: changing to a new vial of extract, 5; dosing error or inappropriate dose adjustment, 5; allergen season, 5; symptomatic before injection, 4; not waiting after injection, 2; and home injection, 1. Onset of anaphylaxis occurred within 20 minutes in eleven patients, within 20 to 30 minutes in one, and after more than 30 minutes in one. In eleven cases the cause of death was associated with respiratory compromise. These data reinforce the need for special precautions in treating high-risk patients with asthma. The annual fatality rate from administration of allergenic extracts in the United States remains very low: 1 fatality per 2 million doses, but additional educational efforts to further reduce the fatality rate are needed.
引用
收藏
页码:6 / 15
页数:10
相关论文
共 31 条
[1]  
[Anonymous], 1986, BMJ-BRIT MED J, V293, P948
[2]  
BAAGOE KH, 1928, UGESKRIFT LAEGER, V90, P550
[3]   EFFECT OF AZELASTINE ON THE SEASONAL INCREASE IN NONSPECIFIC BRONCHIAL RESPONSIVENESS TO METHACHOLINE IN POLLEN ALLERGIC PATIENTS - A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED, CROSSOVER STUDY [J].
BALZANO, G ;
GALLO, C ;
MASI, C ;
COCCO, G ;
FERRANTI, P ;
MELILLO, E ;
SECCIA, G .
CLINICAL AND EXPERIMENTAL ALLERGY, 1992, 22 (03) :371-377
[4]   DEATH DURING SKIN TESTING [J].
BLANTON, WB ;
SUTPHIN, AK .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1949, 217 (02) :169-173
[5]   IMMUNOTHERAPY WITH A STANDARDIZED DERMATOPHAGOIDES-PTERONYSSINUS EXTRACT .3. SYSTEMIC REACTIONS DURING THE RUSH PROTOCOL IN PATIENTS SUFFERING FROM ASTHMA [J].
BOUSQUET, J ;
HEJJAOUI, A ;
DHIVERT, H ;
CLAUZEL, AM ;
MICHEL, FB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (04) :797-802
[6]   AN INSTANCE OF FATAL REACTION TO PENICILLIN SCRATCH-TEST [J].
DOGLIOTTI, M .
DERMATOLOGICA, 1968, 136 (06) :489-&
[7]  
ESCH RE, 1992, ARB PEI GSH, V85, P171
[8]   THE PREVALENCE OF ALLERGIC SKIN-TEST REACTIVITY TO 8 COMMON AEROALLERGENS IN THE UNITED-STATES POPULATION - RESULTS FROM THE 2ND NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY [J].
GERGEN, PJ ;
TURKELTAUB, PC ;
KOVAR, MG .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 80 (05) :669-679
[9]   SUDDEN DEATH DUE TO ALLERGY TESTS [J].
HARRIS, MC ;
SHURE, N .
JOURNAL OF ALLERGY, 1950, 21 (03) :208-216
[10]   IMMUNOTHERAPY WITH A STANDARDIZED DERMATOPHAGOIDES-PTERONYSSINUS EXTRACT .4. SYSTEMIC REACTIONS ACCORDING TO THE IMMUNOTHERAPY SCHEDULE [J].
HEJJAOUI, A ;
DHIVERT, H ;
MICHEL, FB ;
BOUSQUET, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (02) :473-479